Literature DB >> 14151168

TESTOSTERONE PROPIONATE THERAPY IN BREAST CANCER.

I S GOLDENBERG.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS; CASTRATION; CLINICAL RESEARCH; MENOPAUSE; NEOPLASM STATISTICS; NEOPLASM THERAPY; OVARY; PROGNOSIS; TESTOSTERONE

Mesh:

Substances:

Year:  1964        PMID: 14151168     DOI: 10.1001/jama.1964.03060380037009

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  19 in total

Review 1.  Targeting the androgen receptor in breast cancer.

Authors:  KeeMing Chia; Megan O'Brien; Myles Brown; Elgene Lim
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

2.  Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin.

Authors:  Christopher C Coss; Amanda Jones; James T Dalton
Journal:  Invest New Drugs       Date:  2016-04-22       Impact factor: 3.850

3.  Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.

Authors:  Ya-Xuan Liu; Ke-Jing Zhang; Li-Li Tang
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

4.  The value of prognostic parameters for the stratification of advanced breast cancer patients.

Authors:  R Mörz; M Francesconi; M Schemper; H Rainer; J Jakesz; K Moser
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

Review 5.  Impact of estrogens in males and androgens in females.

Authors:  Stephen R Hammes; Ellis R Levin
Journal:  J Clin Invest       Date:  2019-05-01       Impact factor: 14.808

6.  Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study.

Authors:  S M Swain; S M Steinberg; C Bagley; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

7.  Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Authors:  S Dauvois; S M Li; C Martel; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

8.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

Review 9.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28

10.  Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.

Authors:  F Labrie; S Li; A Bélanger; J Côté; Y Mérand; M Lepage
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.